Source link : https://www.newshealth.biz/health-news/aga-issues-guidance-on-using-p-cabs/
Clinicians generally shouldn’t use potassium-competitive acid blockers (P-CAB) as first-line therapy for acid-related conditions, nonerosive gastroesophageal reflux disease (GERD), or peptic ulcer disease, according to a recent clinical practice update from the American Gastroenterological Association (AGA). However, P-CABs are recommended in place of proton pump inhibitors (PPIs) for most patients with Helicobacter pylori and other […]
Author : News Health
Publish date : 2025-01-10 12:20:03
Copyright for syndicated content belongs to the linked Source.